Distinct Gene Expression Patterns of Calcium Channels and Related Signaling Pathways Discovered in Lymphomas

Cell surface calcium (Ca(2+)) channels permit Ca(2+) ion influx, with Ca(2+) taking part in cellular functions such as proliferation, survival, and activation. The expression of voltage-dependent Ca(2+) (Ca(V)) channels may modulate the growth of hematologic cancers. Profile analysis of Ca(2+) channels, with a focus on the Ca(2+) release-activated Ca(2+) (CRAC) and L-type Ca(V) channels, was performed on RNA sequencing data from lymphoma cell lines and samples derived from patients with diffuse large B cell lymphoma (DLBCL). Ca(V)1.2 expression was found to be elevated in classical Hodgkin lymphoma (CHL) cell lines when compared to other B cell lymphoma cell lines. In contrast, CHL exhibited reduced expression of ORAI2 and STIM2. In our differential expression analysis comparing activated B cell-like DLBCL (ABC-DLBCL) and germinal centre B cell-like DLBCL (GCB-DLBCL) patient samples, ABC-DLBCL revealed stronger expression of Ca(V)1.3, whereas Ca(V)1.1, Ca(V)1.2, and Ca(V)1.4 showed greater expression levels in GCB-DLBCL. Interestingly, no differences in ORAI/STIM expression were noted in the patient samples. As Ca(2+) is known to bind to calmodulin, leading to calcineurin activation and the passage of nuclear factor of activated T cells (NFAT) to the cell nucleus, pathways for calcineurin, calmodulin, NFAT, and Ca(2+) signaling were also analyzed by gene set enrichment analysis. The NFAT and Ca(2+) signaling pathways were found to be upregulated in the CHL cell lines relative to other B cell lymphoma cell lines. Furthermore, the calmodulin and Ca(2+) signaling pathways were shown to be downregulated in the ABC-DLBCL patient samples. The findings of this study suggest that L-type Ca(V) channels and Ca(2+)-related pathways could serve as differentiating components for biologic therapies in targeted lymphoma treatments.